| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Scientific Strategy &CSO
1 company
Lamb Peter is an EVP, Scientific Strategy &CSO at EXELIXIS, INC.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $22.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2021 | EXEL Exelixis, Inc. | EVP, Scientific Strategy &CSO | Sale+OE | 65,000 | $22.08 | $1,435,200.00 | -18.7% | |
| Jan 4, 2021 | EXEL Exelixis, Inc. | EVP, Scientific Strategy &CSO | Sale+OE | 65,000 | $20.32 | $1,320,800.00 | -18.7% | |
| Dec 18, 2020 | EXEL Exelixis, Inc. | EVP, Scientific Strategy &CSO | Sale+OE | 65,000 | $20.01 | $1,300,650.00 | -18.7% | |
| Jun 8, 2020 | EXEL Exelixis, Inc. | EVP, Scientific Strategy &CSO | Sale+OE | 26,000 | $22.56 | $586,560.00 | -17.0% | |
| May 7, 2020 | EXEL Exelixis, Inc. | EVP, Scientific Strategy &CSO | Sale+OE | 50,000 | $25.54 | $1,277,000.00 | -28.3% | |
| Apr 6, 2020 | EXEL Exelixis, Inc. | EVP, Scientific Strategy &CSO | Sale+OE | 50,000 | $17.26 | $863,000.00 | -28.3% | |
| Jun 18, 2019 | EXEL Exelixis, Inc. | EVP, Scientific Strategy &CSO | Sale+OE | 217,404 | $20.59 | $4,477,307.04 | -38.2% | |
| Jun 13, 2019 | EXEL Exelixis, Inc. | EVP, Scientific Strategy &CSO | Sale+OE | 27,596 | $20.03 | $552,747.88 | -19.1% |